Home/Pipeline/N-NOSE

N-NOSE

Multi-cancer early detection screening

CommercialAvailable in Japan

Key Facts

Indication

Multi-cancer early detection screening

Phase

Commercial

Status

Available in Japan

Company

Hirotsu Bio Science

About Hirotsu Bio Science

Develops non-invasive cancer screening tests using nematodes' olfactory sensors combined with AI for early detection.

View full company profile

Therapeutic Areas